Clinical Trials Directory

Trials / Completed

CompletedNCT01024543

Role of Angiotensin II in Insulin-induced Microvascular Activity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

In this study we hypothesize infusion of Angiotensin II improves the insulin-induced microvascular dilatation and therefore insulin-mediated glucose uptake. Objectives: Does infusion of Angiotensin II increase insulin-mediated glucose uptake via enhanced insulin-mediated microvascular function in healthy subjects?

Conditions

Interventions

TypeNameDescription
DRUGAngiotensin IIAngiotensin II
DRUGPhenylephrinePhenylephrine
DRUGPlacebo

Timeline

Start date
2006-10-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2009-12-02
Last updated
2009-12-02

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01024543. Inclusion in this directory is not an endorsement.

Role of Angiotensin II in Insulin-induced Microvascular Activity (NCT01024543) · Clinical Trials Directory